PCR218 Evaluating the Adherence of Reporting Patient Reported Outcomes to the Consort PRO Extension, CONSORT-Outcomes Extension and ISOQOL Standards Among Aggressive Large B Cell Lymphoma Patients: Systematic Literature Review of RCTs

I. Yunusa,J. Kallich,T. Eguale,N.M. Patel,U. Patel,A. Thirugnanam,J. Doucette,R. Kandikatla,A.F. Mohamed

doi:10.1016/j.jval.2023.03.2397

PCR218 Evaluating the Adherence of Reporting Patient Reported Outcomes to the Consort PRO Extension, CONSORT-Outcomes Extension and ISOQOL Standards Among Aggressive Large B Cell Lymphoma Patients: Systematic Literature Review of RCTs

I. Yunusa, J. Kallich + Show 7 more

https://doi.org/10.1016/j.jval.2023.03.2397

Copy DOI

Journal: Value in Health

Publication Date: Jun 1, 2023

Affiliation: University of South Carolina, MCPHS University

#Cell Lymphoma Patients #Large B Cell Lymphoma + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

To evaluate the adherence of reporting Patient Reported Outcomes (PROs) to the 2013 CONSORT PRO extension, CONSORT-Outcomes 2022 extension and ISOQOL standards in Randomized Control Trials (RCTs) among Aggressive Large B Cell Lymphoma (LBCL) patients.

Full Text